Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study
In a prospective cohort study, Joanna Shepherd and colleagues use whole blood transcriptome and flow cytometry analyses to identify cell populations and genes associated with a focused immune response very early after injury that develops into a widespread immune dysregulation and multiple organ dysfunction.
Vyšlo v časopise:
Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study. PLoS Med 14(7): e32767. doi:10.1371/journal.pmed.1002352
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002352
Souhrn
In a prospective cohort study, Joanna Shepherd and colleagues use whole blood transcriptome and flow cytometry analyses to identify cell populations and genes associated with a focused immune response very early after injury that develops into a widespread immune dysregulation and multiple organ dysfunction.
Zdroje
1. Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014;384(9952):1455–65. doi: 10.1016/S0140-6736(14)60687-5 25390327
2. Shepherd JM, Cole E, Brohi K. Contemporary patterns of multiple organ dysfunction in trauma. Shock. 2017 Apr;47(4):429–435. doi: 10.1097/SHK.0000000000000779 27798537
3. Sauaia A, Moore EE, Johnson JL, Chin TL, Banerjee A, Sperry JL, et al. Temporal trends of postinjury multiple-organ failure: still resource intensive, morbid, and lethal. J Trauma Acute Care Surg. 2014;76(3):582–92. doi: 10.1097/TA.0000000000000147 24553523
4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2 25530442
5. GBD 2013 DALYs and HALE Collaborators. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015; 386(10009):2145–91 doi: 10.1016/S0140-6736(15)61340-X 26321261
6. Haagsma JA, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany EC, et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev. 2016;22(1):3–18. doi: 10.1136/injuryprev-2015-041616 26635210
7. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, Andermahr J, et al. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock. 2003;20(6):497–502. doi: 10.1097/01.shk.0000095058.62263.1f 14625472
8. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996;40(4):501–10. 8614027
9. Tschoeke SK, Hellmuth M, Hostmann A, Ertel W, Oberholzer A. The early second hit in trauma management augments the proinflammatory immune response to multiple injuries. J Trauma. 2007;62(6):1396–403. doi: 10.1097/TA.0b013e318047b7f0 17563655
10. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al; Inflammation and Host Response to Injury Large Scale Collaborative Research Program. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–90.
11. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma.2003;54(6):1127–30. doi: 10.1097/01.TA.0000069184.82147.06 12813333
12. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307–10. doi: 10.1097/TA.0b013e3180324124 17297317
13. Oyeniyi BT, Fox EE, Scerbo M, Tomasek JS, Wade CE, Holcomb JB. Trends in 1029 trauma deaths at a level 1 trauma center: Impact of a bleeding control bundle of care. Injury. 2017;48(1):5–12. doi: 10.1016/j.injury.2016.10.037 27847192
14. Langan NR, Eckert M, Martin MJ. Changing patterns of in-hospital deaths following implementation of damage control resuscitation practices in US forward military treatment facilities. JAMA Surg. 2014;149(9):904–12. doi: 10.1001/jamasurg.2014.940 25029432
15. Manson J, Cole E, De'Ath HD, Vulliamy P, Meier U, Pennington D, et al. Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients. Crit Care. 2016;20(1):176. doi: 10.1186/s13054-016-1341-2 27268230
16. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187–96. 4814394
17. Copes WS, Champion HR, Sacco WJ, Lawnick MM, Gann DS, Gennarelli T, et al. Progress in characterizing anatomic injury. J Trauma. 1990;30(10):1200–7. 2213928
18. Antonelli M, Moreno R, Vincent JL, Sprung CL, Mendoça A, Passariello M, et al. Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med. 1999;25(4):389–94. 10342513
19. Ciesla DJ, Moore EE, Johnson JL, Sauaia A, Cothren CC, Moore JB, et al. Multiple organ dysfunction during resuscitation is not postinjury multiple organ failure. Arch Surg. 2004;139(6):590–4. doi: 10.1001/archsurg.139.6.590 15197083
20. Pachot A, Monneret G, Voirin N, Leissner P, Venet F, Bohé J, et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol. 2005;114(1):61–9. doi: 10.1016/j.clim.2004.08.015 15596410
21. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–27. doi: 10.1093/biostatistics/kxj037 16632515
22. Shi W, Oshlack A, Smyth GK. Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res. 2010;38(22):e204. doi: 10.1093/nar/gkq871 20929874
23. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi: 10.1093/nar/gkv007 25605792
24. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21(9): 2067–2075. doi: 10.1093/bioinformatics/bti270 15657102
25. Benjamini Y & Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Statist. Soc. B. 1995;57:289–300.
26. Theocharidis A, van Dongen S, Enright AJ, Freeman TC. Network visualization and analysis of gene expression data using BioLayout Express(3D). Nat Protoc. 2009;4(10):1535–50. doi: 10.1038/nprot.2009.177 19798086
27. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F, et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun. 2005;6(4):319–31. doi: 10.1038/sj.gene.6364173 15789058
28. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004;20(9):1453–4. doi: 10.1093/bioinformatics/bth078 14871861
29. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29(1):150–64. doi: 10.1016/j.immuni.2008.05.012 18631455
30. G2 Trial 8 Modules.http://www.biir.net/public_wikis/module_annotation/V2_Trial_8_Modules.
31. Yaari G, Bolen CR, Thakar J, Kleinstein SH. Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations. Nucleic Acids Res. 2013;41(18):e170. doi: 10.1093/nar/gkt660 23921631
32. Turner JA, Bolen CR, Blankenship DM. Quantitative gene set analysis generalized for repeated measures, confounder adjustment, and continuous covariates. BMC Bioinformatics. 2015;16:272. doi: 10.1186/s12859-015-0707-9 26316107
33. Pinheiro JC, Bates DM. Mixed effects models in S and S-PLUS. New York: Springer-Verlag; 2000.
34. Schneider DF, Glenn CH, Faunce DE. Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis. J Burn Care Res. 2007;28(3):365–79. doi: 10.1097/BCR.0B013E318053D40B 17438501
35. Hua R, Zhang Y, Chen F, Zhou Z, Li X, Shao B, et al. Decreased levels of perforin-positive lymphocytes are associated with posttraumatic complications in patients with major trauma. Injury. 2014;45(12):2089–95. doi: 10.1016/j.injury.2014.09.011 25304160
36. Yadav K, Zehtabchi S, Nemes PC, Miller AC, Azher M, Durkin H, Sinert R. Early immunologic responses to trauma in the emergency department patients with major injuries. Resuscitation. 2009;80(1):83–8. doi: 10.1016/j.resuscitation.2008.09.012 18995945
37. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–501. doi: 10.1097/TA.0b013e318256e000 22695412
38. Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, et al. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014;76(1):21–9. doi: 10.1097/TA.0b013e3182ab1ab5 24368353
39. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012;122(1):327–36. doi: 10.1172/JCI57990 22156198
40. Namas RA, Vodovotz Y, Almahmoud K, Abdul-Malak O, Zaaqoq A, Namas R, et al. Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans. Ann Surg. 2016;263(1):191–8. doi: 10.1097/SLA.0000000000001001 25371118
41. Minei JP, Cuschieri J, Sperry J, Moore EE, West MA, Harbrecht BG, et al.; Inflammation and the Host Response to Injury Collaborative Research Program. The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med. 2012;40(4):1129–35.
42. Sordi R, Nandra KK, Chiazza F, Johnson FL, Cabrera CP, Torrance HD et al. Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation. Ann Surg. 2017;265(2):408–417. doi: 10.1097/SLA.0000000000001664 28059970
43. Hazeldine J, Hampson P, Lord JM. The impact of trauma on neutrophil function. Injury. 2014;45(12):1824–33. doi: 10.1016/j.injury.2014.06.021 25106876
44. Leliefeld PH, Wessels CM, Leenen LP, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care. 2016; 20:73. doi: 10.1186/s13054-016-1250-4 27005275
45. Desai KH, Tan CS, Leek JT, Maier RV, Tompkins RG, Storey JD; Inflammation and the Host Response to Injury Large-Scale Collaborative Research Program. Dissecting inflammatory complications in critically injured patients by within-patient gene expression changes: a longitudinal clinical genomics study. PLoS Med. 2011;8(9):e1001093. doi: 10.1371/journal.pmed.1001093 21931541
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study
- Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines
- Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
- Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models